Citadel Advisors’s Candel Therapeutics CADL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,636
| Closed | -$54.4K | – | 5926 |
|
2025
Q1 | $54.4K | Sell |
9,636
-281,513
| -97% | -$1.59M | ﹤0.01% | 5335 |
|
2024
Q4 | $2.53M | Buy |
291,149
+291,048
| +288,166% | +$2.53M | ﹤0.01% | 2368 |
|
2024
Q3 | $700 | Buy |
+101
| New | +$700 | ﹤0.01% | 5640 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 5979 |
|
2024
Q1 | – | Sell |
-16,852
| Closed | -$24.8K | – | 6159 |
|
2023
Q4 | $24.8K | Sell |
16,852
-15,300
| -48% | -$22.5K | ﹤0.01% | 5323 |
|
2023
Q3 | $29.9K | Buy |
+32,152
| New | +$29.9K | ﹤0.01% | 5221 |
|
2023
Q2 | – | Sell |
-47,174
| Closed | -$64.6K | – | 5854 |
|
2023
Q1 | $64.6K | Buy |
+47,174
| New | +$64.6K | ﹤0.01% | 5073 |
|
2022
Q4 | – | Sell |
-16,851
| Closed | -$53K | – | 6100 |
|
2022
Q3 | $53K | Buy |
+16,851
| New | +$53K | ﹤0.01% | 5294 |
|